MedPath

Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque

Completed
Conditions
Dental Plaque
Interventions
Drug: Positive control dentifrice
Drug: Negative control dentifrice
Drug: Stannous fluoride dentifrice
Registration Number
NCT04006483
Lead Sponsor
Procter and Gamble
Brief Summary

The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2359
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Positive control dentifricePositive control dentifriceTwice daily brushing
Negative control dentifriceNegative control dentifriceTwice daily brushing
Stannous Fluoride DentifriceStannous fluoride dentifriceTwice daily brushing
Primary Outcome Measures
NameTimeMethod
Dental Plaque ScoresUp to 12 weeks

Change from baseline as measured by mean plaque score reduction from baseline (via Quigley-Hein, Turesky Modification Index or Rustogi Modification of the Navy Plaque index).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Multiple P&G Investigation Clinical Sites

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath